Novel Therapies: Biological Targets
Iressa (Iressa no longer being offered)
- Cancer Advances: News from the 2004 ASCO Annual Meeting: Drug Shows Activity in Advanced BAC (6/9/04)
- New IRESSA(R) (Gefitinib) Data Presented in Bronchioalveolar Lung Cancer (6/5/04)
- Discovery Promises Better Use of Iressa for Lung Cancer (4/29/04)
- New Pill (Iressa) May Improve Lung Cancer (5/20/02)
- ZD 1839 - Iressa (4/17/02)
Tarceva
- Tarceva®, Formerly Known as OSI-774, An Epidermal Growth Factor Receptor (EGFR) Inhibitor (7/29/02)
Taxotere
- Taxotere (docetaxel) (4/23/02)
- H.L. Moffitt Anticipates Taxotere Trial. A phase II study suspended on April 25, 1997